 New York, NY, Jan. 28, 2021 GLOBE NEWSWIRE -- Biotech Acquisition Company the Company announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at 10.00 per unit, resulting in gross proceeds of 230,000,000. 